The Latin American trauma device market will grow moderately through 2028, largely driven by an expanding aging population, increasing injuries sustained due to traffic accidents, increased physician training, greater access to health care across the region, and the growing use of premium-priced devices. However, the trauma device market will be limited by pricing pressures and a challenging reimbursement environment in the Latin America region.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for trauma devices in Latin America across a 10-year period.
Several manufacturers have recently expanded their product portfolios with the introduction of new devices or by acquiring companies with complementary products.
Which competitors are using the breadth of their product portfolios to secure trauma device market shares?
Which companies have expanded their offerings?
Which segments are seeing increased interest from competitors, and why?
The Latin American trauma device market will continue to grow through 2028.
Which device segments are growing the fastest, and why?
Which device segment is seeing declines, and what is contributing to this?
Rising awareness among patients and increased surgical training will drive demand for premium-priced devices; however, uptake of these products will be somewhat restricted by hospital budget constraints.
Which type of premium devices will continue to display revenue growth despite these pressures?
Which countries will face the greatest pricing pressures?
In the Latin American trauma device market, there is strong competition between MNCs and domestic players, leading to price declines.
What are the key competitive strategies used by domestic competitors to remain competitive in the trauma device market?
What other strategies are MNCs using to remain competitive in the face of strong pricing pressures?
How will purchasing priorities in this region evolve going forward?
- Trauma Devices - Market Insights - Latin America
Author(s): Raghav Tangri, MRes
Raghav Tangri is a senior analyst within the Orthopedics, Dental, and Aesthetics Medtech Insights team at Decision Resources Group, specializing in aesthetics device markets. Raghav has been featured in the Aesthetics Journal and has participated in several white papers on policy advocacy and analysis. Raghav also has expertise in the endoscopy device space, including the markets for gastrointestinal devices, open and laparoscopic devices, and hernia repair devices. Raghav holds a Bachelor's degree in Biotechnology from Delhi Technological University and a Master's degree in Life Sciences from Imperial College London.
Follow Raghav on Twitter:@rtangri_DRG